Nicole LaBrosse
Director of Finance/CFO at HALOZYME THERAPEUTICS, INC.
Net worth: 629 726 $ as of 2024-03-30
Profile
Nicole LaBrosse is currently the Director at Antares Pharma, Inc. and the Chief Financial Officer & Senior Vice President at Halozyme Therapeutics, Inc. She previously worked as an Auditor at PricewaterhouseCoopers LLP from 2004 to 2015.
Ms. LaBrosse has an undergraduate and graduate degree from Bentley University and a graduate degree from McCallum Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-25 | 15,480 ( 0.01% ) | 629 726 $ | 2024-03-30 |
Nicole LaBrosse active positions
| Companies | Position | Start |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director of Finance/CFO | 2022-02-01 |
| ANTARES PHARMA, INC. | Director/Board Member | 2022-05-23 |
Former positions of Nicole LaBrosse
| Companies | Position | End |
|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 2014-12-31 |
Training of Nicole LaBrosse
| McCallum Graduate School of Business | Graduate Degree |
| Bentley University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Stock Market
- Insiders
- Nicole LaBrosse
